Search Results 11-20 of 907 for ��������� ������ ���������katalk:ZA31���24������ ������������ ������ ��������� ������ ������������������������������,������������������,������������������,���������������������,������������������������������

  1. Oncology (Medical) - Clinical trials - Mayo Clinic

    This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC).

  2. Combination birth control pills - Mayo Clinic

    Inactive pills do not contain hormones. Formulations containing 24 active pills and four inactive pills, known as a shortened pill-free interval, also are ...

  3. CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in Patients With Symptomatic oHCM - Mayo Clinic

    CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in ...

  4. Tapentadol (oral route) - Mayo Clinic

    It is very important that your doctor check your progress at regular visits, especially within the first 24 to 72 hours of treatment. This will allow your ...

  5. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

    Rochester, Minnesota: 24-011987. NCT ID: NCT06798012. Sponsor Protocol Number: TAK-411-2001. About this study. The purpose of this study is to assess the effect ...

  6. Oncology (Medical) - Clinical trials - Mayo Clinic

    Rochester, Minn. The purpose of this study is to evaluate how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the ...

  7. Holter monitor - Mayo Clinic

    Accessed Jan. 24, 2022. AskMayoExpert. Ambulatory heart rhythm monitoring. Mayo Clinic; 2021. Medical review (expert opinion). Mayo Clinic. Dec. 5, 2018.

  8. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  9. ... FX24,378 278000026,28399,CATHETER CV 45CMX28FR PLNDRM 2 LUM VENATRAC 16FRX28CM,498.12 278000026,28408,CATH QNT HD PERIT 57,125.86 278000026,4076,CATHETER ...

  10. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...